$7.61
-0.04-0.52%
Last update: Nov 11, 4:00 PM
Aura Biosciences Inc
AURANASDAQ
Aura Biosciences rose 36.6% from $5.57 to $7.61, ahead of the S&P 500's +11.2%. Its worst day was Jul 6 (−8.4%), and its low came Jan 20 at $4.97.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.40 beat the $-0.46 estimate on $0.00 revenue.
−0.7% · S&P 500 −1.7%
Aura Biosciences shares rose 11.1%, while the S&P 500 rose 0.9%.
Story events cover the past 12 months · Times ET
+11.1% · S&P 500 +0.9%
Aura Biosciences closed at its lowest level of the year, 10.8% below where the year started.
−1.0% · S&P 500 −2.0%
Aura Biosciences shares rose 13.5%, while the S&P 500 rose 1.0%.
+13.5% · S&P 500 +1.0%
EPS of $-0.37 beat the $-0.43 estimate on $0.00 revenue.
−1.1% · S&P 500 −0.3%
Aura Biosciences shares rose 19.1%, while the S&P 500 fell 0.4%.
+19.1%, the year's best day · S&P 500 −0.4%
EPS of $-0.50 missed the $-0.40 estimate on $0.00 revenue.
−3.2% · S&P 500 −0.2%
Aura Biosciences shares rose 15.0%, while the S&P 500 fell 0.1%.
+15.0% · S&P 500 −0.1%
EPS of $-0.48 missed the $-0.38 estimate on $0.00 revenue.
+4.4% · S&P 500 −0.3%
EPS of $-0.29 beat the $-0.36 estimate on $0.00 revenue.
+16.8% · S&P 500 +2.4%
Where it ended: a close of $7.61 on Nov 11, 2026.
Nothing in the past 12 months.
All AURA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AURA and SPY from Benzinga historical bars. Not investment advice.
